225Ac-ETN029; 111In-ETN029

날짜

2031년 8월 29일 추정

대상 질환

소세포폐암; Large Cell Neuroendocrine Carcinoma of the Lung; Neuroendocrine Prostate Cancer; Gastroenteropancreatic Neuroendocrine Carcinoma; Non-prostate Extrapulmonary Neuroendocrine Carcinoma; Cervical Neuroendocrine Carcinoma; Thymic Neuroendocrine Carcinoma; Genitourinary Neuroendocrine Carcinoma; Unknown Primary Neuroendocrine Carcinomas; 메르켈세포암; Medullary Thyroid Carcinoma

단계

임상 결과 발표 예정

출처

ClinicalTrials.gov NCT07006727 (새 창)